LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 1401 | 3753 | 4223 | 0.8887 | 0.8334 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 1401 | 4151 | 4223 | 0.9829 | 0.9745 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 1401 | 3851 | 4223 | 0.9119 | 0.8681 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 1 | C10 | 72 | hr | 1401 | 4365 | 4223 | 1.0336 | 1.0503 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 2 | C10 | 72 | hr | 1401 | 4049 | 4223 | 0.9588 | 0.9383 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 3 | C10 | 72 | hr | 1401 | 3564 | 4223 | 0.8439 | 0.7664 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 1 | M16 | 72 | hr | 1401 | 1233 | 4223 | 0.2920 | -0.0597 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 2 | M16 | 72 | hr | 1401 | 1403 | 4223 | 0.3322 | 0.0005 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 3 | M16 | 72 | hr | 1401 | 1405 | 4223 | 0.3327 | 0.0012 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 1 | K16 | 72 | hr | 1401 | 3674 | 4223 | 0.8700 | 0.8054 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 2 | K16 | 72 | hr | 1401 | 4043 | 4223 | 0.9574 | 0.9362 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 3 | K16 | 72 | hr | 1401 | 4064 | 4223 | 0.9623 | 0.9436 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1401 | 2819 | 4223 | 0.6675 | 0.5024 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1401 | 2905 | 4223 | 0.6879 | 0.5329 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1401 | 2812 | 4223 | 0.6659 | 0.4999 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 1 | C04 | 72 | hr | 1401 | 4037 | 4223 | 0.9559 | 0.9341 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 2 | C04 | 72 | hr | 1401 | 4160 | 4223 | 0.9851 | 0.9776 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 3 | C04 | 72 | hr | 1401 | 4051 | 4223 | 0.9593 | 0.9390 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 1 | E04 | 72 | hr | 1401 | 4003 | 4223 | 0.9479 | 0.9220 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 2 | E04 | 72 | hr | 1401 | 3235 | 4223 | 0.7660 | 0.6498 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 3 | E04 | 72 | hr | 1401 | 3845 | 4223 | 0.9105 | 0.8660 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 1401 | 4689 | 4223 | 1.1103 | 1.1651 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 1401 | 3957 | 4223 | 0.9370 | 0.9057 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 1401 | 4192 | 4223 | 0.9926 | 0.9890 |
| SK-BR-3 | PD184352 | 0.37 | uM | LJP5 | 1 | L10 | 72 | hr | 1401 | 4191 | 4223 | 0.9924 | 0.9886 |